Effects of γ-tocotrienol on apoB synthesis, degradation, and secretion in HepG2 cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 3, 1999, Pages 704-712

  Theriault, Andre ^a   Wang, Qi ^a   Gapor, Abdul ^b   Adeli, Khosrow ^c  

^a UNIVERSITY OF HAWAII   (United States)

^b Palm Oil Research Institute of Malaysia   (Malaysia)

^c Bio C 206 ^*

Author keywords

apoB; Degradation; HMG CoA reductase inhibitor; Tocopherol; Tocotrienol

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; GAMMA TOCOTRIENOL; TOCOPHEROL DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT;

EID: 0033046657     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.3.704     Document Type: Article

References (55)

1. Kottke BA, Zinsmeister AR, Holmes DR. Apolipoproteins and coronary artery disease. Mayo Clinic Proc. 1986;61:313-320.
2. Schaefer EJ, McNamara JR, Genest J, Ordovas JM. Genetics and abnormalities in metabolism of lipoproteins. Clin Chem. 1988;34:B9-B12.
3. Adeli K, Sinkevitch C. Secretion of apolipoprotein B in serum-free cultures of human hepatoma cell line, HepG2. FEBS Lett. 1990;263: 345-348.
4. Hahn SE, Goldberg DM. Modulation of lipoprotein production in HepG2 cells by fenofibrate and clofibrate. Biochem Pharmacol. 1992;43: 625-633.
5. Borchardt RA, Davis RA. Intrahepatic assembly of very low density lipoproteins: rate of transport out of the endoplasmic reticulum determines rate of secretion. J Biol Chem. 1987;262:16394-16402.
6. Adeli K, Mohammadi A, Macri J. Regulation of apolipoprotein B biogenesis in human hepatocytes: posttranscriptional control mechanisms that determine the hepatic production of apolipoprotein B-containing lipoproteins. Clin Biochem. 1995;28:123-130.
7. Davis RA, Vance JE. Structure, assembly and secretion of lipoproteins. In: DE Vance, JE Vance, eds. Biochemistry of Lipids, Lipoproteins and Membranes. New York: Elsevier Science; 1996:473-493.
8. Bonnardel JA, Davis RA. In HepG2 cells, translocation, not degradation, determines the fate of the de novo synthesized apolipoprotein B. J Biol Chem. 1995;270:28892-28896.
9. Davis RA, Thrift RN, Wu CC, Howell KE. Apolipoprotein B is both integrated into and translocated across the endoplasmic reticulum membrane. J Biol Chem. 1990;265:10005-10011.
10. Sato R, Imanaka T, Takatsuki A, Takano T. Degradation of newly synthesized apolipoprotein B-100 in a pre-Golgi compartment. J Biol Chem. 1990;265:11880-11884.
11. Rusinol AE, Vance JE. Inhibition of secretion of truncated apolipoproteins B by monomethylethanolamine is independent of the length of the apolipoprotein. J Biol Chem. 1995;270:13318-13325.
12. Yeung SJ, Chen SH, Chan L. Ubiquitin-proteosome pathway mediates intracellular degradation of apolipoprotein B. Biochemistry. 1996;35: 13843-13848.
13. Adeli K, Macri J, Mohammadi A, Kito M, Urade R, Cavallo D. Apolipoprotein B is intracellularly associated with an ER-60 protease homologue in HepG2 cells. J Biol Chem. 1997;272:22489-22494.
14. Furukawa S, Sakata, N, Ginsberg HN, Dixon JL. Studies of the sites of intracellular degradation of apolipoprotein B in HepG2 cells. J Biol Chem. 1992;267:22630-22638.
15. Du EZ, Kurth J, Wang S-L, Humiston P, Davis RA. Proteolysis-coupled secretion of the N-terminus of apolipoprotein B. J Biol Chem. 1994;269: 24169-24176.
16. Du EZ, Wang L-S, Kayden HJ, Sokol R, Curtiss LK, and Davis RA. Translocation of apolipoprotein B across the endoplasmic reticulum is blocked in abetalipoproteinemia. J Lipid Res. 1996;37:1309-1315.
17. Sniderman AD, Cianflone K. Substrate delivery as a determinant of hepatic apoB secretion. Arterioscler Thromb. 1993;13:629-636.
18. Dixon JL, Furukawa S, Ginsberg HN. Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from HepG2 cells by inhibiting early intracellular degradation of apolipoprotein B. J Biol Chem. 1991; 266:5080-5086.
19. Sakata N, Wu X, Dixon JL, Ginsberg HN. Proteolysis and lipid facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in HepG2 cells. J Biol Chem. 1993;268: 22967-22970.
20. Macri J, Adeli K. Studies on intracellular translocation of apolipoprotein B in a permeabilized HepG2 system. J Biol Chem. 1997;272:7328-7337.
21. Sparks JD, Sparks CE. Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. J Biol Chem. 1990;265: 8854-8862.
22. Adeli K, Theriault A. Insulin modulation of human apolipoprotein B mRNA translation: studies in an in vitro cell-free system from HepG2 cells. Biochem Cell Biol. 1992;70:1301-1312.
23. Pearce BC, Parker RA, Deason ME, Qureshi AA, Wright JJK. Hypocholesterolemic activity of synthetic and natural tocotrienols. J Med Chem. 1992;35:3595-3606.
24. 2, and platelet factor 4 in pigs with inherited hyperlipidemias. Am J Clin Nutr. 1991;53:1042S-1046S.
25. Qureshi AA, Qureshi N, Wright JJK, Shen Z, Kramer G, Gapor A, Chong YH, DeWitt G, Ong ASH, Peterson DM, Bradlow BA. Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienol. Am J Clin Nutr. 1991;53:1021S-1026S.
26. Parker RA, Pearce BC, Clark RW, Gordon DA, Wright JJK. Tocotrienols regulate cholesterol production in mammalian cells by posttranscriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. J Biol Chem. 1993;268:11230-11238.
27. Qureshi AA, Bradlow BA, Brace L, Manganello J, Peterson DM, Pearce BC, Wright JJK, Gapor A, Elson CE. Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids. 1995;30:1171-1177.
28. Qureshi AA, Bradlow BA, Salser WA, Brace LD. Novel tocotrienols of rice bran modulate cardiovascular disease risk parameters of hypercholesterolemic humans. J Nutr Biochem. 1997;8:290-298.
29. Huff MW, Burnett JR. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and hepatic apolipoprotein B secretion. Curr Opin Lipidol. 1997;8:138-145.
30. Javitt NB. HepG2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids. FASEB J. 1990;4:161-168.
31. Ginsberg HN. Synthesis and secretion of apolipoprotein B from cultured liver cells. Curr Opin Lipidol. 1995;6:275-280.
32. Adeli K. Regulated intracellular degradation of apolipoprotein B in semi-permeable HepG2 cells. J Biol Chem. 1994;269:9166-9175.
33. Goldstein J, Basu S, Brown M. Assay of cholesteryl ester formation in cultured cells. Methods Enzymol. 1983;98:257-260.
34. Adeli K, Wettesten M, Asp L, Mohammadi A, Macri J, Olofsson S-O. Intracellular assembly and degradation of apolipoprotein B-100-containing lipoproteins in digitonin-permeabilized HepG2 cells. J Biol Chem. 1997;272:5031-5039.
35. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
36. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
37. Gay RJ, McComb RB, Bowers GN Jr. Optimum reaction conditions for human lactate dehydrogenase isoenzymes as they affect total lactate dehydrogenase activity. Clin Chem. 1968;14:740-744.
38. Sallach SM, Adeli K. Intracellular degradation of apolipoprotein B generates an N-terminal 70 kDa fragment in the endoplasmic reticulum. Biochim Biophys Acta. 1995;1265:29-32.
39. Pearce BC, Parker RA, Deason ME, Dischino DD, Gillespie E, Qureshi AA, Volk K, Wright JJK. Inhibitors of cholesterol biosynthesis 2: hypocholesterolemic and antioxidant activities of benzopyran and tetrahydronaphthalene analogues of the tocotrienols. J Med Chem. 1994;37: 526-541.
40. Kamat JP, Devasagayam TPA. Tocotrienols from palm oil as potent inhibitors of lipid peroxidation and protein oxidation in rat brain mitochondria. Neurosci Lett. 1995;195:179-182.
41. Rahmat A, Zurinah W, Ngah W, Shamaan NA, Gapor A, Kadir KA. Long term administration of tocotrienols and tumor-marker enzyme activities during hepatocarcinogenesis in rats. Nutrition. 1993;9:229-232.
42. Nesaretnam K, Guthrie N, Chambers AF, Carroll KK. Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids. 1995;30:1139-1143.
43. Ginsberg HN. Role of lipid synthesis, chaperone proteins and proteosomes in the assembly and secretion of apoproteinB-containing lipoproteins from cultured liver cells. Clin Exp Pharmacol Physiol. 1997; 24:A29-A32.
44. Petrova GV, Kapralov AA, Donchenko GV. Effect of vitamin E on transcription in isolated nuclei and rat liver chromatin in normal status and in E-hypovitaminosis. Biokhimiya. 1991;56:2052-2059.
45. Mohammadi A, Macri J, Newton R, Romain T, Dulay D, Adeli K. Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells. Arterioscler Thromb Vasc Biol. 1998;18: 783-793.
46. Cianflone KM, Yasruel Z, Rodriquez MA, Vas D, Sniderman AD. Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl esters synthesis in the response to a fatty acid challenge. J Lipid Res. 1990;31:2045-2055.
47. Musanti R, Giorgini L, Lovisolo P, Pirillo A, Chiari A, Ghiselli G. Inhibition of acyl-CoA:cholesterol acyltransferase decreases apolipoprotein B-100-containing lipoprotein secretion from HepG2 cells. J Lipid Res. 1996;27:1-14.
48. Tanaka M, Jingami H, Otani H, Cho M, Ueda Y, Arai H, Nagano Y, Doi T, Yokode M, Kita T. Regulation of apolipoprotein B production and secretion in response to the change of intracellular cholesteryl ester contents in rabbit hepatocytes. J Biol Chem. 1993;268:12713-12718.
49. Qin W, Infante J, Wang S-R, Infante R. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in HepG2, human and rat hepatocytes. Biochim Biophys Acta. 1992;1127:57-66.
50. Wu X, Sakata N, Lui E, Ginsberg HN. Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B containing lipoprotein from HepG2 cells by cholesterol esters. J Biol Chem. 1994;269: 12375-12382.
51. Sato R, Imanaka T, Takano T. The effect of HMG-CoA reductase inhibitor (CS-514) on the synthesis and secretion of apolipoprotein B and A-1 in the human hepatoblastoma HepG2. Biochim Biophys Acta. 1990;1042: 36-41.
52. Ribeiro A, Mangeney M, Loriette C, Thomas G, Pepin D, Janvier B, Chambaz J, Bereziat G. Effect of simvastatin on the synthesis and secretion of lipoproteins in relation to the metabolism of cholesterol in cultured hepatocytes. Biochim Biophys Acta. 1991;1086:279-286.
53. Furukawa S, Hirano T. Rapid stimulation of apolipoprotein B secretion by oleate is not associated with cholesterol ester biosynthesis in HepG2 cells. Biochim Biophys Acta. 1993;1170:32-37.
54. Cartwright IJ, Higgins JA, Wilkinson J, Bellavia S, Kendrick JS, Graham JM. Investigation of the role of lipids in the assembly of very low density lipoproteins in rabbit hepatocytes. J Lipid Res. 1997;38:531-545.
55. Qureshi AA, Pearce BC, Nor RM, Gapor A, Peterson DM, Elson CE. Dietary α-tocopherol attenuates the impact of γ-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens. J Nutr. 1996;126:389-394.